FDA Application
-
NDC Search Results on Active Ingredient: ibuprofen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
PHENYLEPHRINE HYDROCHLORIDE; IBUPROFEN | 52904-782-04 | Select Corporation | NDA022565 | HUMAN OTC DRUG | NDA |
PHENYLEPHRINE HYDROCHLORIDE; IBUPROFEN | 52904-782-50 | Select Corporation | NDA022565 | HUMAN OTC DRUG | NDA |
IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE | 0573-0199-22 | Haleon US Holdings LLC | NDA022565 | HUMAN OTC DRUG | NDA |
IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE | 0573-0199-01 | Haleon US Holdings LLC | NDA022565 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-40 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-41 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-89 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0134-20 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-04 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-91 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-88 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-05 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0230-40 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-80 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-01 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-81 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-20 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0134-80 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0133-02 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
IBUPROFEN SODIUM | 0573-0230-20 | Haleon US Holdings LLC | NDA201803 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 72260-129-01 | AFT Pharmaceuticals Ltd | NDA209471 | HUMAN PRESCRIPTION DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 67751-211-02 | Navajo Manufacturing Company Inc. | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 67751-211-01 | Navajo Manufacturing Company Inc. | NDA211733 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0573-0147-90 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 0573-0145-02 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0573-0147-91 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0573-0147-72 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0573-0147-36 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0573-0147-95 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 66715-9601-3 | Lil' Drug Store Products, Inc. | NDA211733 | HUMAN OTC DRUG | NDA |
-